QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (71) Citing Articles via Google Scholar Google Scholar Articles by Price, M. L. Articles by Lucki, I. Search for Related Content PubMed PubMed Citation Articles by Price, M. L. Articles by Lucki, I. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 2001, 21(8):2833-2841

Regulation of Serotonin Release in the Lateral Septum and Striatum by Corticotropin-Releasing Factor

Michelle L. Price¹ and Irwin Lucki^{1, 2}

¹ David Mahoney Institute of Neurological Sciences and ² Departments of Psychiatry and Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104

The serotonergic dorsal raphé nucleus (DRN) is innervated by corticotropin-releasing factor (CRF)-immunoreactive fibers and contains CRF receptor-binding sites, suggesting that endogenous CRF regulates this system. The present study examined the possibility that CRF in the DRN regulates the release of serotonin (5-HT) in forebrain terminal regions. Intracerebroventricular administration of CRF produced a bimodal effect on extracellular levels of 5-HT in the lateral septum. Doses of 0.3 and 1.0 µg decreased extracellular 5-HT levels, whereas both a higher (3.0 µg) and a lower (0.1 µg) dose had no effect. The reduction of extracellular 5-HT in the lateral septum by CRF (0.3 µg, i.c.v.) was blocked by pretreatment with the CRF receptor antagonist D-PheCRF_12-41 (3.0 µg, i.c.v.). Direct administration of CRF (30 ng) into the DRN reduced extracellular 5-HT levels in the lateral septum and the striatum. Furthermore, injection of D-PheCRF_12-41 (10 ng) into the DRN before ventricular administration of CRF (0.3 µg, i.c.v.) blocked the decrease in extracellular 5-HT in both the lateral septum and striatum. Taken together, these data support the hypothesis that CRF may modulate 5-HT release in terminal regions via its effects at the level of the DRN. This modulation supports a potential interaction between CRF and 5-HT in stress-related psychiatric disorders in which both systems have been implicated.

Key words: corticotropin-releasing hormone; serotonin; dorsal raphé nucleus; microdialysis; lateral septum; striatum

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/2182833-09$05.00/0

This article has been cited by other articles:

				S. Movafagh, J. P. Hobson, S. Spiegel, H. K. Kleinman, and Z. Zukowska Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors FASEB J, September 1, 2006; 20(11): 1924 - 1926. [Abstract] [Full Text] [PDF]

				A J. DUNN, A H SWIERGIEL, and V PALAMARCHOUK Brain Circuits Involved in Corticotropin-Releasing Factor-Norepinephrine Interactions during Stress Ann. N.Y. Acad. Sci., June 1, 2004; 1018(1): 25 - 34. [Abstract] [Full Text] [PDF]

				H. Tan, P. Zhong, and Z. Yan Corticotropin-Releasing Factor and Acute Stress Prolongs Serotonergic Regulation of GABA Transmission in Prefrontal Cortical Pyramidal Neurons J. Neurosci., May 26, 2004; 24(21): 5000 - 5008. [Abstract] [Full Text] [PDF]

				L. Pernar, A. L. Curtis, W. W. Vale, J. E. Rivier, and R. J. Valentino Selective Activation of Corticotropin-Releasing Factor-2 Receptors on Neurochemically Identified Neurons in the Rat Dorsal Raphe Nucleus Reveals Dual Actions J. Neurosci., February 11, 2004; 24(6): 1305 - 1311. [Abstract] [Full Text] [PDF]

				T. L. Bale and W. W. Vale Increased Depression-Like Behaviors in Corticotropin-Releasing Factor Receptor-2-Deficient Mice: Sexually Dichotomous Responses J. Neurosci., June 15, 2003; 23(12): 5295 - 5301. [Abstract] [Full Text] [PDF]

				M. Roche, K. G. Commons, A. Peoples, and R. J. Valentino Circuitry Underlying Regulation of the Serotonergic System by Swim Stress J. Neurosci., February 1, 2003; 23(3): 970 - 977. [Abstract] [Full Text] [PDF]

				S. E. Hammack, M. J. Schmid, M. L. LoPresti, A. Der-Avakian, M. A. Pellymounter, A. C. Foster, L. R. Watkins, and S. F. Maier Corticotropin Releasing Hormone Type 2 Receptors in the Dorsal Raphe Nucleus Mediate the Behavioral Consequences of Uncontrollable Stress J. Neurosci., February 1, 2003; 23(3): 1019 - 1025. [Abstract] [Full Text] [PDF]

				A. D. Le, S. Harding, W. Juzytsch, P. J. Fletcher, and Y. Shaham The Role of Corticotropin-Releasing Factor in the Median Raphe Nucleus in Relapse to Alcohol J. Neurosci., September 15, 2002; 22(18): 7844 - 7849. [Abstract] [Full Text] [PDF]

				M. A. Pelleymounter, M. Joppa, N. Ling, and A. C. Foster Pharmacological Evidence Supporting a Role for Central Corticotropin-Releasing Factor2 Receptors in Behavioral, but not Endocrine, Response to Environmental Stress J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 145 - 152. [Abstract] [Full Text] [PDF]

				S. E. Hammack, K. J. Richey, M. J. Schmid, M. L. LoPresti, L. R. Watkins, and S. F. Maier The Role of Corticotropin-Releasing Hormone in the Dorsal Raphe Nucleus in Mediating the Behavioral Consequences of Uncontrollable Stress J. Neurosci., February 1, 2002; 22(3): 1020 - 1026. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help